In addition to its function in cell proliferation, SLC39A4 is reported to upregulate the expression of VEGFs in pancreatic cancer by upregulating its receptor NRP‐1, revealing an autocrine signaling pathway involving the ZIP4–VEGF–NRP‐1 axis.32, 64. Here, NRP1 is linked to familial pancreatic carcinoma.